Cargando…
Ovarian carcinoma immunoreactive antigen domain 2 controls mitochondrial apoptosis in lung adenocarcinoma
Ovarian carcinoma immunoreactive antigen domain 2 (OCIAD2) has been reported to show significantly higher expression in invasive lung adenocarcinoma than in lung adenocarcinoma in situ, and its abnormal expression is associated with poorer prognosis of the patients. However, the cellular function of...
Autores principales: | Hong, Jeongmin, Shiba‐Ishii, Aya, Kim, Yunjung, Noguchi, Masayuki, Sakamoto, Noriaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645747/ https://www.ncbi.nlm.nih.gov/pubmed/34628698 http://dx.doi.org/10.1111/cas.15160 |
Ejemplares similares
-
Carcinogen‐induced tumors in SFN‐transgenic mice harbor a characteristic mutation spectrum of human lung adenocarcinoma
por: Kim, Yunjung, et al.
Publicado: (2019) -
DNA hypomethylation-related overexpression of SFN, GORASP2 and ZYG11A is a novel prognostic biomarker for early stage lung adenocarcinoma
por: Husni, Ryan Edbert, et al.
Publicado: (2019) -
miR‐3941: A novel microRNA that controls IGBP1 expression and is associated with malignant progression of lung adenocarcinoma
por: Sato, Taiki, et al.
Publicado: (2017) -
Stratifin accelerates progression of lung adenocarcinoma at an early stage
por: Shiba-Ishii, Aya, et al.
Publicado: (2015) -
High expression of Ras‐specific guanine nucleotide‐releasing factor 2 (RasGRF2) in lung adenocarcinoma is associated with tumor invasion and poor prognosis
por: Nakagawa, Tomoki, et al.
Publicado: (2021)